Immunocore Holdings plc - American Depositary Shares —— 季度财务数据 (NASDAQ:IMCR) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -13.95 M435 K25.96 M-4.46 M-32.66 M -10.71 M 投资活动产生的现金 -3.54 M9.7 M-30.41 M5.25 M-880 K -16.34 M 融资活动产生的现金 -51.51 M2.55 M3.67 M1.87 M4.28 M 12.37 M 自由现金流 -17.54 M137 K25.55 M-5.2 M-35.53 M -15.05 M

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

新闻

Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma

Jefferies因营收担忧下调Immunocore股票评级

Jefferies downgrades Immunocore stock rating on revenue concerns

Immunocore在Leerink会议上展示战略增长与创新

Immunocore at Leerink Conference: Strategic Growth and Innovation

Immunocore Holdings plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-02-25

Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript

Immunocore HoldingsQ4每股收益及营收逊于预期

Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates

JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y